Symbols / PRCT Stock $28.11 +8.49% PROCEPT BioRobotics Corporation

Healthcare • Medical Devices • United States • NGM
PRCT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Larry L. Wood
Exch · Country NGM · United States
Market Cap 1.60B
Enterprise Value 1.43B
Income -102.47M
Sales 322.02M
FCF (ttm) -43.18M
Book/sh 6.11
Cash/sh 4.32
Employees 888
Insider 10d —
IPO Sep 15, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -32.46
PEG —
P/S 4.97
P/B 4.60
P/C —
EV/EBITDA -13.99
EV/Sales 4.45
Quick Ratio 5.38
Current Ratio 6.73
Debt/Eq 22.43
LT Debt/Eq —
EPS (ttm) -1.83
EPS next Y -0.87
EPS Growth —
Revenue Growth 20.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-29
Earnings (prior) 2026-04-29
ROA -13.54%
ROE -27.82%
ROIC —
Gross Margin 63.97%
Oper. Margin -39.22%
Profit Margin -31.82%
Shs Outstand 56.92M
Shs Float 55.59M
Insider Own 3.13%
Instit Own 102.64%
Short Float 10.86%
Short Ratio 4.37
Short Interest 6.00M
52W High 66.85
vs 52W High -57.95%
52W Low 19.35
vs 52W Low 45.27%
Beta 0.83
Impl. Vol. 1.56%
Rel Volume 0.81
Avg Volume 1.79M
Volume 1.46M
Target (mean) $30.44
Tgt Median $31.00
Tgt Low $20.00
Tgt High $37.00
# Analysts 9
Recom Buy
Prev Close $25.91
Price $28.11
Change 8.49%
About

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$30.44
Mean price target
2. Current target
$28.11
Latest analyst target
3. DCF / Fair value
$-13.65
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$28.11
Low
$20.00
High
$37.00
Mean
$30.44

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-30 reit Piper Sandler Overweight → Overweight $35
2026-03-06 init Baird — → Neutral $30
2026-03-02 main Truist Securities Buy → Buy $30
2026-02-26 main Leerink Partners Outperform → Outperform $30
2026-02-26 main TD Cowen Buy → Buy $34
2026-02-26 down Oppenheimer Outperform → Perform —
2026-02-26 main Piper Sandler Overweight → Overweight $28
2026-02-26 main Wells Fargo Overweight → Overweight $34
2026-02-26 down B of A Securities Neutral → Underperform $20
2025-12-18 main Truist Securities Buy → Buy $47
2025-12-12 init UBS — → Buy $62
2025-12-08 down B of A Securities Buy → Neutral $38
2025-12-02 main Morgan Stanley Overweight → Overweight $51
2025-11-05 main TD Cowen Buy → Buy $50
2025-11-05 reit Piper Sandler Overweight → Overweight $50
2025-11-05 main Wells Fargo Overweight → Overweight $51
2025-10-15 main Truist Securities Buy → Buy $50
2025-09-16 reit BTIG Neutral → Neutral —
2025-09-02 up Oppenheimer Perform → Outperform $60
2025-08-07 main Wells Fargo Overweight → Overweight $58
News
RSS: Latest PRCT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-19 NOURI ALALEH Officer — 5,363 $25.82 $139,231
2026-03-17 NOURI ALALEH Officer — 304 $28.15 $8,559
2026-03-17 WATERS KEVIN Chief Financial Officer — 706 $28.15 $19,876
2026-03-10 NOURI ALALEH Officer — 3,243 $25.60 $83,197
2026-03-09 DESAI ANTAL ROHIT Director — 426,262 $23.33 $10,482,943
2026-03-06 NOURI ALALEH Officer — 6,892 $23.70 $163,353
2026-03-06 WATERS KEVIN Chief Financial Officer — 6,721 $23.70 $159,300
2026-03-05 WOOD LARRY L Chief Executive Officer — 127,783 $0.00 $0
2026-03-05 NOURI ALALEH Officer — 43,811 $0.00 $0
2026-03-05 WATERS KEVIN Chief Financial Officer — 47,462 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
308.05
+37.22%
224.50
+64.84%
136.19
+81.55%
75.01
Operating Revenue
308.05
+37.22%
224.50
+64.84%
136.19
+81.55%
75.01
Cost Of Revenue
111.83
+27.95%
87.40
+34.17%
65.14
+71.75%
37.93
Reconciled Cost Of Revenue
111.83
+27.95%
87.40
+34.17%
65.14
+71.75%
37.93
Gross Profit
196.23
+43.13%
137.10
+92.96%
71.05
+91.58%
37.09
Operating Expense
300.08
+28.40%
233.71
+29.68%
180.22
+52.98%
117.81
Research And Development
71.28
+14.41%
62.30
+28.59%
48.45
+67.16%
28.98
Selling General And Administration
228.81
+33.48%
171.41
+30.08%
131.77
+48.35%
88.83
Total Expenses
411.91
+28.28%
321.11
+30.87%
245.36
+57.55%
155.74
Operating Income
-103.86
-7.50%
-96.61
+11.50%
-109.17
-35.24%
-80.72
Total Operating Income As Reported
-103.86
-7.50%
-96.61
+11.50%
-109.17
-35.24%
-80.72
EBITDA
-85.41
-4.63%
-81.63
+16.72%
-98.02
-23.87%
-79.13
Normalized EBITDA
-85.41
-4.78%
-81.51
+16.75%
-97.91
-29.53%
-75.59
Reconciled Depreciation
6.39
+22.09%
5.23
+37.48%
3.81
+34.00%
2.84
EBIT
-91.80
-5.68%
-86.86
+14.69%
-101.82
-24.22%
-81.97
Total Unusual Items
—
-0.11
-6.54%
-0.11
+96.98%
-3.54
Total Unusual Items Excluding Goodwill
—
-0.11
-6.54%
-0.11
+96.98%
-3.54
Special Income Charges
—
0.00
0.00
+100.00%
-3.26
Other Special Charges
—
—
—
3.26
Net Income
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Pretax Income
-95.38
-4.76%
-91.05
+13.96%
-105.82
-21.41%
-87.15
Net Non Operating Interest Income Expense
8.63
+28.64%
6.71
+88.72%
3.56
+232.39%
-2.69
Interest Expense Non Operating
3.59
-14.29%
4.18
+4.73%
4.00
-22.92%
5.18
Net Interest Income
8.63
+28.64%
6.71
+88.72%
3.56
+232.39%
-2.69
Interest Expense
3.59
-14.29%
4.18
+4.73%
4.00
-22.92%
5.18
Interest Income Non Operating
12.22
+12.15%
10.89
+44.29%
7.55
+202.40%
2.50
Interest Income
12.22
+12.15%
10.89
+44.29%
7.55
+202.40%
2.50
Other Income Expense
-0.16
+86.34%
-1.14
-462.56%
-0.20
+94.58%
-3.74
Other Non Operating Income Expenses
-0.16
+84.82%
-1.03
-970.83%
-0.10
+52.71%
-0.20
Gain On Sale Of Security
—
-0.11
-6.54%
-0.11
+62.19%
-0.28
Tax Provision
0.19
-48.37%
0.37
+360.00%
0.08
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Net Income From Continuing Operation Net Minority Interest
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Net Income From Continuing And Discontinued Operation
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Net Income Continuous Operations
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Normalized Income
-95.57
-4.68%
-91.30
+13.70%
-105.79
-26.52%
-83.61
Net Income Common Stockholders
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Diluted EPS
-1.72
+1.71%
-1.75
+21.88%
-2.24
-14.29%
-1.96
Basic EPS
-1.72
+1.71%
-1.75
+21.88%
-2.24
-14.29%
-1.96
Basic Average Shares
55.54
+6.56%
52.12
+10.31%
47.26
+6.43%
44.40
Diluted Average Shares
55.54
+6.56%
52.12
+10.31%
47.26
+6.43%
44.40
Diluted NI Availto Com Stockholders
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
508.08
-4.86%
534.02
+31.95%
404.72
+30.84%
309.33
Current Assets
450.38
-6.53%
481.84
+37.45%
350.57
+28.59%
272.63
Cash Cash Equivalents And Short Term Investments
286.50
-14.15%
333.73
+29.74%
257.22
+15.94%
221.86
Cash And Cash Equivalents
286.50
-14.15%
333.73
+29.74%
257.22
+15.94%
221.86
Cash Equivalents
275.09
-14.77%
322.76
+28.79%
250.61
+17.66%
212.99
Cash Financial
11.42
+4.16%
10.96
+65.85%
6.61
-25.49%
8.87
Receivables
83.53
+0.04%
83.50
+72.60%
48.38
+216.76%
15.27
Accounts Receivable
83.53
+0.04%
83.50
+72.60%
48.38
+216.76%
15.27
Inventory
70.69
+25.86%
56.17
+41.28%
39.76
+39.28%
28.54
Raw Materials
18.62
+2.35%
18.19
+53.73%
11.83
-4.71%
12.42
Work In Process
13.45
+17.42%
11.45
+89.38%
6.05
+247.93%
1.74
Finished Goods
38.63
+45.63%
26.53
+21.26%
21.88
+52.05%
14.39
Prepaid Assets
—
—
—
—
Restricted Cash
—
—
0.00
-100.00%
0.78
Other Current Assets
9.65
+14.14%
8.45
+62.15%
5.21
-15.58%
6.17
Total Non Current Assets
57.70
+10.60%
52.17
-3.65%
54.15
+47.54%
36.70
Net PPE
47.94
+5.01%
45.65
-6.82%
48.99
+52.44%
32.14
Gross PPE
60.69
+13.48%
53.48
+1.56%
52.66
+27.99%
41.14
Accumulated Depreciation
-12.75
-62.86%
-7.83
-113.41%
-3.67
+59.25%
-9.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
21.84
+10.97%
19.68
+36.89%
14.38
+341.07%
3.26
Construction In Progress
4.11
+1468.32%
0.26
-92.62%
3.55
-37.44%
5.67
Other Properties
21.51
+2.21%
21.05
-5.91%
22.37
-17.97%
27.27
Leases
13.22
+5.90%
12.49
+1.02%
12.36
+150.19%
4.94
Goodwill And Other Intangible Assets
0.71
-23.93%
0.93
-22.59%
1.20
-18.48%
1.48
Other Intangible Assets
0.71
-23.93%
0.93
-22.59%
1.20
—
Other Non Current Assets
9.06
+61.93%
5.59
+41.34%
3.96
+28.10%
3.09
Total Liabilities Net Minority Interest
142.21
+7.90%
131.80
+6.32%
123.97
+10.43%
112.26
Current Liabilities
65.80
+23.83%
53.13
+15.69%
45.93
+30.14%
35.29
Payables And Accrued Expenses
19.97
+51.71%
13.16
-15.95%
15.66
+22.77%
12.76
Payables
18.74
+54.90%
12.10
-20.52%
15.22
+48.96%
10.22
Accounts Payable
17.29
+72.30%
10.03
-25.68%
13.50
+43.74%
9.39
Current Accrued Expenses
1.23
+15.49%
1.06
+142.60%
0.44
-82.70%
2.54
Pensionand Other Post Retirement Benefit Plans Current
23.18
+7.61%
21.54
+27.55%
16.89
+25.57%
13.45
Total Tax Payable
1.46
-29.50%
2.07
+19.88%
1.73
+108.08%
0.83
Current Debt And Capital Lease Obligation
2.21
+15.92%
1.91
+13.49%
1.68
-20.95%
2.13
Current Capital Lease Obligation
2.21
+15.92%
1.91
+13.49%
1.68
-20.95%
2.13
Current Deferred Liabilities
13.05
+36.41%
9.56
+69.11%
5.66
+98.11%
2.85
Current Deferred Revenue
13.05
+36.41%
9.56
+69.11%
5.66
+98.11%
2.85
Other Current Liabilities
7.38
+6.17%
6.96
+19.77%
5.81
+48.88%
3.90
Total Non Current Liabilities Net Minority Interest
76.42
-2.86%
78.66
+0.80%
78.04
+1.39%
76.97
Long Term Debt And Capital Lease Obligation
76.27
-2.64%
78.34
+1.06%
77.52
+3.10%
75.19
Long Term Debt
51.62
+0.28%
51.47
+0.26%
51.34
+0.25%
51.21
Long Term Capital Lease Obligation
24.65
-8.24%
26.87
+2.62%
26.18
+9.21%
23.98
Long Term Provisions
—
—
0.52
—
Other Non Current Liabilities
0.15
-54.63%
0.32
-37.33%
0.52
—
Stockholders Equity
365.87
-9.04%
402.22
+43.27%
280.75
+42.46%
197.07
Common Stock Equity
365.87
-9.04%
402.22
+43.27%
280.75
+42.46%
197.07
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
56.32
+2.93%
54.72
+7.77%
50.77
+13.26%
44.83
Ordinary Shares Number
56.32
+2.93%
54.72
+7.77%
50.77
+13.26%
44.83
Additional Paid In Capital
1,007.39
+6.25%
948.09
+28.95%
735.24
+34.72%
545.75
Retained Earnings
-641.56
-17.50%
-545.99
-20.11%
-454.57
-30.37%
-348.68
Gains Losses Not Affecting Retained Earnings
0.04
-67.54%
0.11
+35.71%
0.08
+1500.00%
-0.01
Other Equity Adjustments
0.04
-67.54%
0.11
+35.71%
0.08
+1500.00%
-0.01
Total Equity Gross Minority Interest
365.87
-9.04%
402.22
+43.27%
280.75
+42.46%
197.07
Total Capitalization
417.49
-7.98%
453.69
+36.62%
332.09
+33.75%
248.28
Working Capital
384.58
-10.29%
428.71
+40.73%
304.64
+28.36%
237.34
Invested Capital
417.49
-7.98%
453.69
+36.62%
332.09
+33.75%
248.28
Total Debt
78.48
-2.20%
80.25
+1.32%
79.20
+2.44%
77.32
Capital Lease Obligations
26.87
-6.64%
28.78
+3.28%
27.86
+6.75%
26.10
Net Tangible Assets
365.16
-9.00%
401.29
+43.55%
279.55
+42.92%
195.59
Tangible Book Value
365.16
-9.00%
401.29
+43.55%
279.55
+42.92%
195.59
Current Provisions
—
—
0.23
+16.00%
0.20
Derivative Product Liabilities
—
—
0.00
-100.00%
1.78
Interest Payable
0.29
-6.13%
0.31
-6.91%
0.33
-37.41%
0.53
Other Inventories
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-48.98
+50.63%
-99.21
+8.14%
-108.00
-34.36%
-80.38
Cash Flow From Continuing Operating Activities
-48.98
+50.63%
-99.21
+8.14%
-108.00
-34.36%
-80.38
Net Income From Continuing Operations
-95.57
-4.55%
-91.41
+13.68%
-105.90
-21.51%
-87.15
Depreciation Amortization Depletion
6.39
+22.09%
5.23
+37.48%
3.81
+34.00%
2.84
Depreciation And Amortization
6.39
+22.09%
5.23
+37.48%
3.81
+34.00%
2.84
Other Non Cash Items
-0.51
-32.64%
-0.38
-3046.15%
0.01
-99.12%
1.48
Stock Based Compensation
47.60
+49.51%
31.84
+66.41%
19.13
+85.10%
10.34
Provisionand Write Offof Assets
0.22
-73.93%
0.84
0.00
0.00
Asset Impairment Charge
0.56
-69.96%
1.88
+89.05%
0.99
+1504.84%
0.06
Operating Gains Losses
0.16
+37.72%
0.11
+6.54%
0.11
-96.98%
3.54
Gain Loss On Investment Securities
—
0.11
+6.54%
0.11
-62.19%
0.28
Net Foreign Currency Exchange Gain Loss
0.16
0.00
0.00
—
Change In Working Capital
-7.84
+83.44%
-47.33
-80.90%
-26.16
-127.75%
-11.49
Change In Receivables
-0.90
+97.50%
-35.96
-8.63%
-33.10
-206.25%
-10.81
Changes In Account Receivables
-0.90
+97.50%
-35.96
-8.63%
-33.10
-206.25%
-10.81
Change In Inventory
-14.50
+15.88%
-17.23
-76.75%
-9.75
+36.06%
-15.25
Change In Prepaid Assets
-1.10
+65.68%
-3.21
-405.52%
1.05
+155.90%
-1.88
Change In Payables And Accrued Expense
8.38
+218.15%
2.63
-71.83%
9.35
-19.99%
11.69
Change In Accrued Expense
1.73
-63.81%
4.79
+34.33%
3.56
-53.90%
7.73
Change In Payable
6.65
+408.92%
-2.15
-137.17%
5.79
+46.22%
3.96
Change In Account Payable
6.65
+408.92%
-2.15
-137.17%
5.79
+46.22%
3.96
Change In Other Working Capital
3.31
-47.62%
6.31
-24.01%
8.31
+353.88%
1.83
Change In Other Current Assets
-2.90
-76.85%
-1.64
-88.59%
-0.87
-1601.96%
-0.05
Change In Other Current Liabilities
-0.13
-107.45%
1.77
+254.13%
-1.15
-138.48%
2.99
Investing Cash Flow
-9.36
-112.20%
-4.41
+82.51%
-25.21
-850.09%
-2.65
Cash Flow From Continuing Investing Activities
-9.36
-112.20%
-4.41
+82.51%
-25.21
-850.09%
-2.65
Net PPE Purchase And Sale
-9.36
-112.20%
-4.41
+82.51%
-25.21
-850.09%
-2.65
Purchase Of PPE
-9.36
-112.20%
-4.41
+82.51%
-25.21
-850.09%
-2.65
Capital Expenditure
-9.36
-112.20%
-4.41
+82.51%
-25.21
-850.09%
-2.65
Financing Cash Flow
11.19
-93.79%
180.12
+7.35%
167.79
+4545.49%
3.61
Cash Flow From Continuing Financing Activities
11.19
-93.79%
180.12
+7.35%
167.79
+4545.49%
3.61
Net Issuance Payments Of Debt
—
0.00
0.00
-100.00%
1.20
Issuance Of Debt
—
0.00
0.00
-100.00%
51.20
Repayment Of Debt
—
0.00
0.00
+100.00%
-50.00
Long Term Debt Issuance
—
0.00
0.00
-100.00%
51.20
Long Term Debt Payments
—
0.00
0.00
+100.00%
-50.00
Net Long Term Debt Issuance
—
0.00
0.00
-100.00%
1.20
Net Common Stock Issuance
0.00
-100.00%
164.52
+1.74%
161.71
0.00
Proceeds From Stock Option Exercised
11.19
-28.26%
15.60
+156.19%
6.09
-5.10%
6.42
Net Other Financing Charges
—
—
—
-4.00
Changes In Cash
-47.15
-161.63%
76.50
+121.20%
34.59
+143.55%
-79.42
Effect Of Exchange Rate Changes
-0.07
0.00
0.00
—
Beginning Cash Position
336.76
+29.39%
260.26
+15.33%
225.67
-26.03%
305.10
End Cash Position
289.54
-14.02%
336.76
+29.39%
260.26
+15.33%
225.67
Free Cash Flow
-58.34
+43.70%
-103.62
+22.21%
-133.21
-60.43%
-83.03
Interest Paid Supplemental Data
3.46
-12.77%
3.97
-2.12%
4.06
-5.48%
4.29
Change In Interest Payable
0.14
+5.97%
0.13
+7.20%
0.12
-83.49%
0.76
Common Stock Issuance
0.00
-100.00%
164.52
+1.74%
161.71
0.00
Issuance Of Capital Stock
0.00
-100.00%
164.52
+1.74%
161.71
0.00
Net Preferred Stock Issuance
—
—
0.00
0.00
Preferred Stock Issuance
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category